ALCON NORDIC A/S: Financial statements 2012
CVR: 15887478
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
ALCON NORDIC A/S (CVR 15887478) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 50,734,000 and a net result of DKK 4,254,000. Equity in the 2012 report amounted to DKK 15,147,000. The solvency ratio was 29.3%. The company had 49 employees in the financial year.
- Gross Profit
- DKK 50,734,000
- Profit/Loss
- DKK 4,254,000
- Equity
- DKK 15,147,000
- Total Assets
- DKK 51,701,000
- Employees
- 49
Official annual report
Keep an eye on ALCON NORDIC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of July 30, 2012, Jean -Claude Dubos has left the board of directors of ALCON NORDIC A/S.
About ALCON NORDIC A/S
ALCON NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 1992. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ALCON DANMARK A/S and ALCON DANMARK ApS. The management consists of Petr Kotelnikov. The board consists of Julien Rosentraub (chair), Petr Kotelnikov and Umut Meric. The company is owned by Alcon Pharmaceuticals Ltd. The company has 75 employees (2026). In 2025, the company reported revenue of DKK 1,060,222,000 and a net result of DKK 42,026,000 compared with DKK 34,391,000 the year before. Equity in the 2025 report amounted to DKK 171,120,000.